Trial Profile

A six-week, randomized, double-blind, quadruple-dummy parallel group multiple dose study comparing the efficacy and safety of tiotropium inhalation capsules plus formoterol inhalation capsules to salmeterol inhalation aerosol plus fluticasone inhalation aerosol in patients with chronic obstructive pulmonary disease (COPD)

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tiotropium bromide (Primary) ; Fluticasone propionate; Formoterol; Salmeterol
Indications Chronic obstructive pulmonary disease
Focus Therapeutic Use

01 Aug 2008 Primary endpoint 'Forced expiratory volume in 1 second' has been met.
01 Aug 2008 Results published in Chest journal.
09 Jan 2008 Status changed from in progress to completed.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com